{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T08:30:08Z","timestamp":1770280208203,"version":"3.49.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T00:00:00Z","timestamp":1727395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T00:00:00Z","timestamp":1727395200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Rheumatol"],"DOI":"10.1186\/s12969-024-01023-w","type":"journal-article","created":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T09:02:35Z","timestamp":1727427755000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Effectiveness and safety of canakinumab in cryopyrin-associated periodic syndrome: a retrospective study in China"],"prefix":"10.1186","volume":"22","author":[{"given":"Xiaona","family":"Zhu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaqi","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanyan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongbin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruohang","family":"Weng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingyan","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,9,27]]},"reference":[{"issue":"3","key":"1023_CR1","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1136\/ard.2010.138420","volume":"70","author":"L Cuisset","year":"2011","unstructured":"Cuisset L, Jeru I, Dumont B, Fabre A, Cochet E, Le Bozec J, et al. Mutations in the autoinflammatory cryopyrin-associated periodic syndrome gene: epidemiological study and lessons from eight years of genetic analysis in France. Ann Rheum Dis. 2011;70(3):495\u20139.","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"1023_CR2","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1136\/annrheumdis-2016-209686","volume":"76","author":"JB Kuemmerle-Deschner","year":"2017","unstructured":"Kuemmerle-Deschner JB, Ozen S, Tyrrell PN, Kone-Paut I, Goldbach-Mansky R, Lachmann H, et al. Diagnostic criteria for cryopyrin-associated periodic syndrome (CAPS). Ann Rheum Dis. 2017;76(6):942\u20137.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"1023_CR3","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s10875-019-00638-z","volume":"39","author":"LM Booshehri","year":"2019","unstructured":"Booshehri LM, Hoffman HM. CAPS and NLRP3. J Clin Immunol. 2019;39(3):277\u201386.","journal-title":"J Clin Immunol"},{"issue":"1","key":"1023_CR4","doi-asserted-by":"publisher","first-page":"128","DOI":"10.3390\/jcm10010128","volume":"10","author":"T Welzel","year":"2021","unstructured":"Welzel T, Kuemmerle-Deschner JB. Diagnosis and management of the Cryopyrin-Associated Periodic Syndromes (CAPS): what do we know today? J Clin Med. 2021;10(1):128.","journal-title":"J Clin Med."},{"issue":"7","key":"1023_CR5","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1136\/annrheumdis-2021-221801","volume":"81","author":"M Romano","year":"2022","unstructured":"Romano M, Arici ZS, Piskin D, Alehashemi S, Aletaha D, Barron KS, et al. The 2021 EULAR\/American College of Rheumatology points to consider for diagnosis, management and monitoring of the interleukin-1 mediated autoinflammatory diseases: cryopyrin-associated periodic syndromes, tumour necrosis factor receptor-associated periodic syndrome, mevalonate kinase deficiency, and deficiency of the interleukin-1 receptor antagonist. Ann Rheum Dis. 2022;81(7):907\u201321.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"1023_CR6","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12969-020-0409-3","volume":"18","author":"S Hansmann","year":"2020","unstructured":"Hansmann S, Lainka E, Horneff G, Holzinger D, Rieber N, Jansson AF, et al. Consensus protocols for the diagnosis and management of the hereditary autoinflammatory syndromes CAPS, TRAPS and MKD\/HIDS: a German PRO-KIND initiative. Pediatr Rheumatol Online J. 2020;18(1):17.","journal-title":"Pediatr Rheumatol Online J"},{"issue":"12","key":"1023_CR7","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1136\/annrheumdis-2013-203666","volume":"73","author":"M Piram","year":"2014","unstructured":"Piram M, Kone-Paut I, Lachmann HJ, Frenkel J, Ozen S, Kuemmerle-Deschner J, et al. Validation of the auto-inflammatory diseases activity index (AIDAI) for hereditary recurrent fever syndromes. Ann Rheum Dis. 2014;73(12):2168\u201373.","journal-title":"Ann Rheum Dis"},{"issue":"23","key":"1023_CR8","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1056\/NEJMoa0810787","volume":"360","author":"HJ Lachmann","year":"2009","unstructured":"Lachmann HJ, Kone-Paut I, Kuemmerle-Deschner JB, Leslie KS, Hachulla E, Quartier P, et al. Use of canakinumab in the cryopyrin-associated periodic syndrome. N Engl J Med. 2009;360(23):2416\u201325.","journal-title":"N Engl J Med"},{"issue":"6","key":"1023_CR9","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1002\/art.42808","volume":"76","author":"T Miyamoto","year":"2024","unstructured":"Miyamoto T, Izawa K, Masui S, Yamazaki A, Yamasaki Y, Matsubayashi T, et al. Clinical characteristics of cryopyrin-associated periodic syndrome and long-term real-world efficacy and tolerability of Canakinumab in Japan: results of a nationwide survey. Arthritis Rheumatol. 2024;76(6):949\u201362.","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"1023_CR10","doi-asserted-by":"publisher","first-page":"e001663","DOI":"10.1136\/rmdopen-2021-001663","volume":"7","author":"UA Walker","year":"2021","unstructured":"Walker UA, Tilson HH, Hawkins PN, Poll TV, Noviello S, Levy J, et al. Long-term safety and effectiveness of canakinumab therapy in patients with cryopyrin-associated periodic syndrome: results from the beta-confident registry. RMD Open. 2021;7(2):e001663.","journal-title":"RMD Open"},{"key":"1023_CR11","doi-asserted-by":"publisher","first-page":"865763","DOI":"10.3389\/fneur.2022.865763","volume":"13","author":"H Nakanishi","year":"2022","unstructured":"Nakanishi H, Yamada S, Kita J, Shinmura D, Hosokawa K, Sahara S, et al. Auditory and vestibular characteristics of NLRP3 inflammasome related autoinflammatory disorders: monogenic hearing loss can be improved by Anti-interleukin-1 therapy. Front Neurol. 2022;13:865763.","journal-title":"Front Neurol"},{"key":"1023_CR12","doi-asserted-by":"publisher","first-page":"1267933","DOI":"10.3389\/fimmu.2023.1267933","volume":"14","author":"Z Shu","year":"2023","unstructured":"Shu Z, Zhang Y, Han T, Li Y, Piao Y, Sun F, et al. The genetic and clinical characteristics and effects of Canakinumab on cryopyrin-associated periodic syndrome: a large pediatric cohort study from China. Front Immunol. 2023;14:1267933.","journal-title":"Front Immunol"},{"issue":"4","key":"1023_CR13","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1093\/rheumatology\/kev416","volume":"55","author":"JB Kuemmerle-Deschner","year":"2016","unstructured":"Kuemmerle-Deschner JB, Hofer F, Endres T, Kortus-Goetze B, Blank N, Weissbarth-Riedel E, et al. Real-life effectiveness of canakinumab in cryopyrin-associated periodic syndrome. Rheumatology (Oxford). 2016;55(4):689\u201396.","journal-title":"Rheumatology (Oxford)"},{"issue":"11","key":"1023_CR14","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1002\/art.41004","volume":"71","author":"PA Brogan","year":"2019","unstructured":"Brogan PA, Hofer M, Kuemmerle-Deschner JB, Kone-Paut I, Roesler J, Kallinich T, et al. Rapid and sustained long-term efficacy and safety of canakinumab in patients with cryopyrin-associated periodic syndrome ages five years and younger. Arthritis Rheumatol. 2019;71(11):1955\u201363.","journal-title":"Arthritis Rheumatol"}],"container-title":["Pediatric Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-024-01023-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12969-024-01023-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-024-01023-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T09:08:41Z","timestamp":1727428121000},"score":1,"resource":{"primary":{"URL":"https:\/\/ped-rheum.biomedcentral.com\/articles\/10.1186\/s12969-024-01023-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,27]]},"references-count":14,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1023"],"URL":"https:\/\/doi.org\/10.1186\/s12969-024-01023-w","relation":{},"ISSN":["1546-0096"],"issn-type":[{"value":"1546-0096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,27]]},"assertion":[{"value":"10 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The studies involving human participants were reviewed and approved by the Ethics Committee of Shenzhen Children\u2019s Hospital. Written informed consent to participate in this study was provided by the participants\u2019 legal guardian.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"We assure that the data presented here was not published elsewhere and the article has not been submitted to any other journal. We give our consent for the publication of the manuscript \u201cEffectiveness and safety of canakinumab in cryopyrin-associated periodic syndrome: a retrospective study in China\u201d.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. Patients accessed canakinumab on their own expenses and without any company participation.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"87"}}